People who received a Johnson & Johnson coronavirus vaccine may be better off with a booster shot from Moderna or Pfizer-BioNTech, according to preliminary data from a federal clinical trial published on Wednesday.That finding, along with a mixed review by the Food and Drug Administration of the case made by Johnson & Johnson for an…
